EmVenio Research
  • Home
  • Who We Are
    • Our Story
    • Our Team
    • Careers
  • Who We Serve
    • Patients
    • Local Communities
    • Research Partners
    • Sponsors
  • What We Offer
    • Global Site Network
    • Mobile & Virtual Visits
    • Patient Engagement
    • Therapeutic Area Focus
  • Resources
    • Insights
    • Events
  • Contact
Select Page
GeoVax and EmVenio Announce Collaboration to Expand Phase 2 COVID-19 Booster Vaccine Clinical Trial

GeoVax and EmVenio Announce Collaboration to Expand Phase 2 COVID-19 Booster Vaccine Clinical Trial

by EmVenio | Feb 15, 2023 | Press Release

Mobile Community Clinical Research Facility to be Deployed in California Atlanta, GA, February 15, 2023 – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, and EmVenio Research, a...
Next Entries »

Recent Posts

  • EmVenio team attends 2025 World Vaccine Congress
  • EmVenio Research wins Best Clinical Trial Company award at 2025 ViE Awards
  • Virtually tour our dedicated research sites within Prime Healthcare
  • The EmVenio and PCM Trials Team Attend SCOPE 2025
  • Efficient Study Start-Up: Best Practices from a Clinical Site Network – A Webinar Recap

Recent Comments

No comments to show.

Partner with us.



Email Us

contact@emvenio.com



call us

+1 (919) 364-0166



Our Location

500 E 8th Street
Denver, CO 80203


Privacy policy

  • Follow
  • Follow
  • Follow
  • Follow
Sign Up To Our Newsletter